Your browser doesn't support javascript.
loading
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
Urtishak, Karen A; Wang, Li-San; Culjkovic-Kraljacic, Biljana; Davenport, James W; Porazzi, Patrizia; Vincent, Tiffaney L; Teachey, David T; Tasian, Sarah K; Moore, Jonni S; Seif, Alix E; Jin, Shenghao; Barrett, Jeffrey S; Robinson, Blaine W; Chen, I-Ming L; Harvey, Richard C; Carroll, Martin P; Carroll, Andrew J; Heerema, Nyla A; Devidas, Meenakshi; Dreyer, ZoAnn E; Hilden, Joanne M; Hunger, Stephen P; Willman, Cheryl L; Borden, Katherine L B; Felix, Carolyn A.
Afiliação
  • Urtishak KA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Wang LS; NewAgeSys, Inc., Princeton Junction, NJ, USA.
  • Culjkovic-Kraljacic B; Department of Pathology and Laboratory Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Davenport JW; Institute of Research in Immunology and Cancer (IRIC), Department of Pathology and Cell Biology, Universite de Montreal, Montreal, QC, Canada.
  • Porazzi P; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Vincent TL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Teachey DT; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Tasian SK; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Moore JS; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Seif AE; Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Jin S; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Barrett JS; Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Robinson BW; Department of Pathology and Laboratory Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Chen IL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Harvey RC; Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Carroll MP; Division of Hematology and Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Carroll AJ; Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Heerema NA; Division of Clinical Pharmacology & Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Devidas M; Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.
  • Dreyer ZE; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Hilden JM; Therapy Acceleration Program, Leukemia & Lymphoma Society, Rye Brook, NY, USA.
  • Hunger SP; Department of Pathology and UNM Cancer Center, University of New Mexico Health Services, Albuquerque, NM, USA.
  • Willman CL; Department of Pathology and UNM Cancer Center, University of New Mexico Health Services, Albuquerque, NM, USA.
  • Borden KLB; Division of Hematology and Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • Felix CA; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Oncogene ; 38(13): 2241-2262, 2019 03.
Article em En | MEDLINE | ID: mdl-30478448
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribavirina / Fator de Iniciação 4E em Eucariotos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Terapia de Alvo Molecular Tipo de estudo: Diagnostic_studies Limite: Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribavirina / Fator de Iniciação 4E em Eucariotos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Terapia de Alvo Molecular Tipo de estudo: Diagnostic_studies Limite: Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2019 Tipo de documento: Article